Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.4
-59.12%
40%
—
-58.91%
40%
—
5 Years
Score3.4
Net Growth-59.12%
Net Trend40%
Net Income Consistency—
Rev Growth-58.91%
Rev Trend40%
Revenue Consistency—
Tekla Healthcare Investors fundamental performance
Between 2005 and 2025, revenue grew from $ 1M to $ 99M and net income grew from $ 62M to $ 98M. Revenue increased in 11 of those 20 years; net income in 10.
Across Tekla Healthcare Investors's full reported history, from 1996 to 2025, revenue grew from $ 250K to $ 99M and net income grew from $ 29M to $ 98M. Revenue increased in 54% of the years measured; net income in 54%.
Tekla Healthcare Investors currently holds a 20-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 23.45 | — |
1 Year2025-08-12 | $ 14.04 | 66.99% |
5 Years2021-08-12 | $ 15.50 | 51.26% |
10 Years2016-08-12 | $ 9.97 | 135.09% |
20 Years2006-08-11 | $ 2.79 | 8x |
30 Years1996-08-12 | $ 1.04 | 22x |
All Time1988-01-05 | $ 0.27 | 86x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1988-01-05 |
|---|---|---|---|---|---|---|---|
| Price | $ 23.45 | $ 14.04 | $ 15.50 | $ 9.97 | $ 2.79 | $ 1.04 | $ 0.27 |
| Return | — | 66.99% | 51.26% | 135.09% | 8x | 22x | 86x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 99M | $ 98M | $ 59.00 |
| 2024 | $ 10M | $ 184M | $ 56.00 |
| 2023 | $ 58M | $ 56M | $ 214.00 |
| 2022 | -$ 192M | -$ 194M | $ 792.00 |
| 2021 | $ 157M | $ 155M | $ 935.00 |
| 2020 | $ 242M | $ 241M | $ 2M |
| 2019 | -$ 143M | -$ 145M | $ 1M |
| 2018 | $ 70M | $ 69M | $ 927.00 |
| 2017 | $ 123M | $ 121M | $ 6M |
| 2016 | $ 4M | -$ 56M | $ 883.00 |
| 2015 | $ 4M | $ 96M | $ 209.55K |
| 2014 | $ 2M | $ 222M | $ 1.12K |
| 2013 | $ 1M | $ 200M | |
| 2012 | $ 5M | $ 157M | |
| 2011 | $ 1M | $ 32M | |
| 2010 | $ 3M | $ 19M | |
| 2009 | $ 720K | -$ 36M | |
| 2008 | $ 2M | -$ 23M | |
| 2007 | $ 2M | $ 75M | |
| 2006 | $ 3M | -$ 15M | |
| 2005 | $ 1M | $ 62M | $ 300K |
| 2004 | $ 690K | $ 13M | $ 200K |
| 2003 | $ 990K | $ 54M | $ 2M |
| 2002 | $ 1M | -$ 75M | |
| 2001 | $ 2M | -$ 140M | $ 600K |
| 2000 | $ 2M | $ 286M | $ 300K |
| 1998 | $ 640K | -$ 47M | $ 200K |
| 1997 | $ 680K | $ 33M | |
| 1996 | $ 250K | $ 29M | $ 300K |
Explore beyond HQH
You're looking at Tekla Healthcare Investors. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
